Current Genmab A/S forecasts and price targets in August 2026

Ø Analyst Price Targets
342.40 USD
+34.84 %
Median
355.52 USD
+40.01 %
Max
3,167.85 USD
Min
1,313.00 USD
Last Price
253.93 USD
Buy
16
Hold
8
Sell
2

The average target price for Genmab A/S is 342.40 USD. (+34.84 % above the current price)

The median price target of Genmab A/S is 355.52 USD.

Stock analysts from many renowned investment banks are closely examining the Genmab A/S stock. They conclude their professional Genmab A/S stock analyses with a clear recommendation for the Genmab A/S stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.

BuyHoldSellØ Analyst Price Targets
2026-04-011782
2026-03-011682342.40 USD
2026-02-011682352.22 USD
2026-02-011682341.94 USD
2026-01-011692333.96 USD
2025-12-011782328.87 USD

Genmab A/S Stock Forecast 2026: Revenue & Earnings Estimates

Analysts expect the following revenue and earnings for Genmab A/S in the coming fiscal years:

Fiscal yearRevenueNet IncomeEarnings per share
2026e4.37 B USD710.00 M USD11.33 USD
2027e5.15 B USD1.05 B USD16.78 USD
2028e6.22 B USD1.56 B USD24.93 USD
Genmab A/S Stock → Genmab A/S Dividend →